SNTI
Price
$2.08
Change
+$0.40 (+23.81%)
Updated
Oct 14 closing price
Capitalization
54.41M
Intraday Buy/Sell Signals
SVRA
Price
$3.38
Change
-$0.03 (-0.88%)
Updated
Oct 14 closing price
Capitalization
585.05M
22 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

SNTI vs SVRA

Header iconSNTI vs SVRA Comparison
Open Charts SNTI vs SVRABanner chart's image
Senti Biosciences
Price$2.08
Change+$0.40 (+23.81%)
Volume$2.72M
Capitalization54.41M
Savara
Price$3.38
Change-$0.03 (-0.88%)
Volume$914.62K
Capitalization585.05M
SNTI vs SVRA Comparison Chart in %
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNTI vs. SVRA commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNTI is a Hold and SVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (SNTI: $2.08 vs. SVRA: $3.38)
Brand notoriety: SNTI and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNTI: 1405% vs. SVRA: 62%
Market capitalization -- SNTI: $54.41M vs. SVRA: $585.05M
SNTI [@Biotechnology] is valued at $54.41M. SVRA’s [@Biotechnology] market capitalization is $585.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNTI’s FA Score shows that 1 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • SNTI’s FA Score: 1 green, 4 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNTI is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNTI’s TA Score shows that 6 TA indicator(s) are bullish while SVRA’s TA Score has 4 bullish TA indicator(s).

  • SNTI’s TA Score: 6 bullish, 4 bearish.
  • SVRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SNTI is a better buy in the short-term than SVRA.

Price Growth

SNTI (@Biotechnology) experienced а +20.23% price change this week, while SVRA (@Biotechnology) price change was -1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

SVRA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($585M) has a higher market cap than SNTI($54.4M). SVRA YTD gains are higher at: 10.098 vs. SNTI (-40.741). SNTI has higher annual earnings (EBITDA): -58.4M vs. SVRA (-116.49M). SVRA has more cash in the bank: 146M vs. SNTI (21.6M). SVRA has less debt than SNTI: SVRA (29.7M) vs SNTI (31.3M). SNTI (0) and SVRA (0) have equivalent revenues.
SNTISVRASNTI / SVRA
Capitalization54.4M585M9%
EBITDA-58.4M-116.49M50%
Gain YTD-40.74110.098-403%
P/E Ratio4.27N/A-
Revenue00-
Total Cash21.6M146M15%
Total Debt31.3M29.7M105%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNTISVRA
RSI
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 8 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
77%
Bullish Trend 8 days ago
80%
Momentum
ODDS (%)
Bullish Trend 8 days ago
51%
Bearish Trend 8 days ago
77%
MACD
ODDS (%)
Bullish Trend 8 days ago
67%
Bearish Trend 8 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
62%
Bearish Trend 8 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
53%
Bearish Trend 8 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend about 1 month ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
79%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
66%
Bearish Trend 10 days ago
80%
Aroon
ODDS (%)
Bullish Trend 8 days ago
44%
Bullish Trend 8 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH35.541.12
+3.27%
Dianthus Therapeutics
EXLS41.010.20
+0.49%
ExlService Holdings
ATCH0.40-0.01
-1.40%
AtlasClear Holdings Inc
NVO56.66-0.84
-1.46%
Novo-Nordisk A/S
AZ6.91-0.14
-1.99%
A2Z Cust2Mate Solutions Corp

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
+23.81%
PPBT - SNTI
60%
Loosely correlated
-2.12%
KRRO - SNTI
44%
Loosely correlated
+0.15%
JANX - SNTI
43%
Loosely correlated
-2.13%
PTCT - SNTI
32%
Poorly correlated
+0.05%
SVRA - SNTI
29%
Poorly correlated
-0.88%
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-0.88%
RCKT - SVRA
61%
Loosely correlated
+23.05%
PRTA - SVRA
46%
Loosely correlated
-2.22%
OCUL - SVRA
40%
Loosely correlated
-5.23%
IFRX - SVRA
39%
Loosely correlated
+2.40%
SRRK - SVRA
38%
Loosely correlated
-6.93%
More